D.C. Diagnosis: AMA gets vocal, pharma’s new lobby group

D.C. Diagnosis: AMA gets vocal, pharma’s new lobby group


You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Season two of the hospital drama “The Pitt” will include storylines that envision how Medicaid cuts in Republicans’ One Big Beautiful Bill will impact hospitals. As someone who has struggled to write about work requirements, provider taxes, and state-directed payments in a way that is understandable and interesting, I’m looking forward to seeing how they handle it. Send your storyline suggestions and news tips to [email protected] or John_Wilkerson.07 on Signal.

AMA speaks up

It’s tough out there for the American Medical Association. It risks drawing undue attention to doctors when speaking out forcefully against administration policies that diverge from medical consensus. But many AMA members fear that “quiet advocacy” isn’t working either, and it runs the risk of making doctors look complacent.

STAT+ Exclusive Story

STAT+





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *